BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32239431)

  • 21. The value of 3D pseudo-continuousarterial spin labeling perfusion imaging in moyamoya disease-Comparison with dynamic susceptibility contrast perfusion imaging.
    Zhang H; Lu M; Liu S; Liu D; Shen X; Sheng F; Han C; Cai J
    Front Neurosci; 2022; 16():944246. PubMed ID: 35992916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients.
    Kim JY; Park JE; Jo Y; Shim WH; Nam SJ; Kim JH; Yoo RE; Choi SH; Kim HS
    Neuro Oncol; 2019 Feb; 21(3):404-414. PubMed ID: 30107606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transit time corrected arterial spin labeling technique aids to overcome delayed transit time effect.
    Yun TJ; Sohn CH; Yoo RE; Kang KM; Choi SH; Kim JH; Park SW; Hwang M; Lebel RM
    Neuroradiology; 2018 Mar; 60(3):255-265. PubMed ID: 29288284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perfusion-weighted techniques in MRI grading of pediatric cerebral tumors: efficiency of dynamic susceptibility contrast and arterial spin labeling.
    Testud B; Brun G; Varoquaux A; Hak JF; Appay R; Le Troter A; Girard N; Stellmann JP
    Neuroradiology; 2021 Aug; 63(8):1353-1366. PubMed ID: 33506349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A linear mixed perfusion model for tissue partial volume correction of perfusion estimates in dynamic susceptibility contrast MRI: Impact on absolute quantification, repeatability, and agreement with pseudo-continuous arterial spin labeling.
    Ahlgren A; Wirestam R; Lind E; Ståhlberg F; Knutsson L
    Magn Reson Med; 2017 Jun; 77(6):2203-2214. PubMed ID: 27321696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of delayed transit time on arterial spin labeling: correlation with dynamic susceptibility contrast perfusion magnetic resonance in moyamoya disease.
    Yun TJ; Sohn CH; Han MH; Kang HS; Kim JE; Yoon BW; Paeng JC; Choi SH; Kim JH; Song IC; Chang KH
    Invest Radiol; 2013 Nov; 48(11):795-802. PubMed ID: 23764569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
    Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
    Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of pulsed-continuous arterial spin labeling and dynamic susceptibility contrast imaging by histogram analysis in evaluation of glial tumors.
    Arisawa A; Watanabe Y; Tanaka H; Takahashi H; Matsuo C; Fujiwara T; Fujiwara M; Fujimoto Y; Tomiyama N
    Neuroradiology; 2018 Jun; 60(6):599-608. PubMed ID: 29705876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arterial spin labeled perfusion MRI for the assessment of radiation-treated meningiomas.
    Manning P; Srinivas S; Bolar DS; Rajaratnam MK; Piccioni DE; McDonald CR; Hattangadi-Gluth JA; Farid N
    Front Radiol; 2024; 4():1345465. PubMed ID: 38562528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intrasession Reliability of Arterial Spin-Labeled MRI-Measured Noncontrast Perfusion in Glioblastoma at 3 T.
    Zhou L; Wang Y; Pinho MC; Pan E; Xi Y; Maldjian JA; Madhuranthakam AJ
    Tomography; 2020 Jun; 6(2):139-147. PubMed ID: 32548290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.
    Goetti R; O'Gorman R; Khan N; Kellenberger CJ; Scheer I
    Neuroradiology; 2013 May; 55(5):639-47. PubMed ID: 23404242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
    Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI.
    Wang DJ; Alger JR; Qiao JX; Hao Q; Hou S; Fiaz R; Gunther M; Pope WB; Saver JL; Salamon N; Liebeskind DS;
    Stroke; 2012 Apr; 43(4):1018-24. PubMed ID: 22328551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of arterial spin labeling perfusion magnetic resonance imaging in prediction of angiographic vascularity of meningiomas.
    Yoo RE; Yun TJ; Cho YD; Rhim JH; Kang KM; Choi SH; Kim JH; Kim JE; Kang HS; Sohn CH; Park SW; Han MH
    J Neurosurg; 2016 Sep; 125(3):536-43. PubMed ID: 26824378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudo-continuous arterial spin labelling shows high diagnostic performance in the detection of postoperative residual lesion in hyper-vascularised adult brain tumours.
    Cohen C; Law-Ye B; Dormont D; Leclercq D; Capelle L; Sanson M; Galanaud D; Pyatigorskaya N
    Eur Radiol; 2020 May; 30(5):2809-2820. PubMed ID: 31965259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between dynamic susceptibility contrast magnetic resonance imaging and arterial spin labeling techniques in distinguishing malignant from benign brain tumors.
    Ata ES; Turgut M; Eraslan C; Dayanır YÖ
    Eur J Radiol; 2016 Sep; 85(9):1545-53. PubMed ID: 27501887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of 3D Arterial Spin Labeling and Multi-Parametric Dynamic Susceptibility Contrast Perfusion MRI in Brain Tumors.
    Khashbat Md D; Abe Md T; Ganbold Md M; Iwamoto Md S; Uyama Md N; Irahara Md S; Otomi Md PhD Y; Harada Md PhD M; Kageji Md PhD T; Nagahiro Md PhD S
    J Med Invest; 2016; 63(3-4):175-81. PubMed ID: 27644554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors.
    Jiang J; Zhao L; Zhang Y; Zhang S; Yao Y; Qin Y; Wang CY; Zhu W
    Int J Clin Exp Pathol; 2014; 7(6):2790-9. PubMed ID: 25031698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of arterial transit time delays on the differentiation between tumor progression and pseudoprogression in glioblastoma by arterial spin labeling magnetic resonance imaging.
    van Dorth D; Jiang FY; Schmitz-Abecassis B; Croese RJI; Taphoorn MJB; Smits M; Koekkoek JAF; Dirven L; de Bresser J; van Osch MJP
    NMR Biomed; 2024 Apr; ():e5166. PubMed ID: 38654579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Consistency analysis between 3D arterial spin labeling and dynamic susceptibility contrast perfusion magnetic resonance imaging in perfusion imaging of brain tumor].
    Chen S; Wang L; Wang L; Zheng C; Yang K
    Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1283-1286. PubMed ID: 34549723
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.